The scale-up receives further investment after the £70 million Series C round last July and accelerates its international expansion
The start-up launched its product just a few weeks ago with an international vision and a clear business model
Start-up founded by University of Turin professors innovates treatment of tumours with KRAS mutation
Vertis leads the new round that opens the scale-up phase, with Crédit Agricole Italia and Open Venture among the co-investors
The figures presented by Italian Tech Alliance and Growth Capital show that last year was the best ever, second only to 2022
The start-up is financed by Claris Ventures, Ora Global, Club degli Investitori and Italian Angels for Growth
The innovative Italian company collaborates with Jackson Laboratory, New York Stem Cell Foundation, UConn Health and the University of Michigan
The start-up, which has its headquarters in Hong Kong, is already active in several markets in Europe, North America and, of course, Asia
Click here to read previous Newsletters
Subscribe to the newsletter
yes
en
* I agree that my personal data will be used in accordance with the Privacy and Cookie Policy.
* I authorize the processing of my personal data to be updated on new arrivals and for direct marketing purposes related to the services offered.